Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does HIGH DENSITY POLYETHYLENE Cause Product use in unapproved indication? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Product use in unapproved indication have been filed in association with HIGH DENSITY POLYETHYLENE. This represents 17.9% of all adverse event reports for HIGH DENSITY POLYETHYLENE.

5
Reports of Product use in unapproved indication with HIGH DENSITY POLYETHYLENE
17.9%
of all HIGH DENSITY POLYETHYLENE reports
0
Deaths
4
Hospitalizations

How Dangerous Is Product use in unapproved indication From HIGH DENSITY POLYETHYLENE?

Of the 5 reports, 4 (80.0%) required hospitalization.

Is Product use in unapproved indication Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for HIGH DENSITY POLYETHYLENE. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does HIGH DENSITY POLYETHYLENE Cause?

Drug ineffective (10) Product use issue (7) Inappropriate schedule of product administration (6) Intentional product misuse (6) Child abuse (5) Drug abuse (5) Drug dependence (5) Epidural lipomatosis (5) Juvenile idiopathic arthritis (5) Obesity (5)

What Other Drugs Cause Product use in unapproved indication?

DUPILUMAB (33,452) DICLOFENAC (12,197) METHOTREXATE (8,930) PREDNISONE (7,625) RITUXIMAB (7,519) MYCOPHENOLATE MOFETIL (5,910) ACETAMINOPHEN (5,819) CYCLOPHOSPHAMIDE (5,750) RISPERIDONE (5,551) TACROLIMUS (5,057)

Related Pages

HIGH DENSITY POLYETHYLENE Full Profile All Product use in unapproved indication Reports All Drugs Causing Product use in unapproved indication HIGH DENSITY POLYETHYLENE Demographics